Literature DB >> 13665517

Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone.

C M KAGAWA, F M STURTEVANT, C G VAN ARMAN.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/antagonists; DESOXYCORTICOSTERONE/antagonists

Mesh:

Substances:

Year:  1959        PMID: 13665517

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  13 in total

1.  [2,4,7-Triamino-6-phenylpteridine as an "aldosterone antagonist"].

Authors:  H HERKEN; G SENFT
Journal:  Klin Wochenschr       Date:  1961-12-01

2.  [Aldosterone-antagonistic spirolactones. II. Clinical aspects].

Authors:  R HILD; F KRUECK
Journal:  Klin Wochenschr       Date:  1961-02-15

3.  [The aldosterone-antagonistic spirolactone. I. Pharmacology].

Authors:  F KRUECK; R HILD
Journal:  Klin Wochenschr       Date:  1960-10-01

4.  The rise of cardiovascular medicine.

Authors:  Eugene Braunwald
Journal:  Eur Heart J       Date:  2012-03-12       Impact factor: 29.983

5.  REDUCTION IN AQUEOUS HUMOUR FORMATION AS CAUSED BY IODATE, SPIROLACTONE, AND POLYPHLORETIN PHOSPHATE.

Authors:  D F Cole
Journal:  Br J Ophthalmol       Date:  1962-05       Impact factor: 4.638

6.  Life and scientific career of C. Gordon Van Arman, Ph.D.

Authors:  Richard P Carlson
Journal:  Inflamm Res       Date:  2009-12-13       Impact factor: 4.575

7.  Diuretics. I. Physiological and pharmacological considerations.

Authors:  J L Anderton; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

8.  Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.

Authors:  G T McInnes; I R Harrison; J R Shelton; R M Perkins
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

Review 9.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

10.  Metabolic studies on patients with resistant heart failure treated by spironolactone.

Authors:  T A BAYLEY; P G FORBATH; J K WILSON; H P HIGGINS
Journal:  Can Med Assoc J       Date:  1962-12-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.